LentiCRISPR v2-Blast 质粒 (编号: V016982)
基本信息
备注:The LentiCRISPR v2-Blast plasmid is a lentiviral vector designed for CRISPR/Cas9-mediated gene knockout in mammalian cells. It expresses the Cas9 nuclease and a customizable single-guide RNA (sgRNA) from different promoters. A key feature is the blasticidin resistance gene, which replaces the original puromycin marker, allowing for selection of transduced cells using blasticidin. In bacteria, the plasmid is selected with ampicillin. Its all-in-one design facilitates efficient delivery and stable expression of CRISPR components for gene editing applications.
- 载体名称
- LentiCRISPR v2-Blast
- 载体抗性
- Ampicillin
- 载体长度
- 14612 bp
- 载体类型
- Gene knockout
- 复制子
- ori
- 宿主
- Mammalian cells, Lentivirus
- 筛选标记
- Blast
- 启动子
- SV40
- 感受态
- Stbl3
- 培养温度
- 37℃
质粒操作方法
质粒复溶方法
- 发货形式:质粒干粉,常温运输,收到后请于 -20 ℃ 保存,先转化提质粒再使用。
- 收到干粉后先 5000 rpm 离心 1 min,加入 20 μl ddH₂O 溶解。质粒复测浓度与标称值可能有差距,这通常来自干粉在管中的位置、复溶效率、测量偏差与管壁吸附,建议先转化提质粒后再使用。
- 取 1 支 100 μl 感受态细胞冰上解冻 10 min,加入 2 μl 质粒,冰浴 30 min,42 ℃ 热激 60 s(不要摇动),再冰浴 2 min。
- 加入 900 μl 无抗生素 LB 液体培养基,180 rpm、37 ℃ 振荡培养 45 min(30 ℃ 培养 1–1.5 h)。
- 6000 rpm 离心 5 min,保留约 100 μl 上清重悬菌体,涂布到对应抗性的 LB 平板。
- 平板倒置 37 ℃ 培养 14 h(30 ℃ 则 20 h)。菌落过多可稀释质粒后再转化;无菌落可增加至 10 μl 质粒。建议先转克隆感受态、重提质粒后再导入表达感受态。
- 挑取单菌落接种 LB 液体培养基,加入对应抗生素,220 rpm 振荡培养 14 h,按试剂盒说明提取质粒。
通用质粒转化方法
- 取100 μL感受态细胞置于冰上解冻10 min,加入2 μL质粒,冰浴30 min;随后42 ℃热激60 s,期间不要晃动,再冰浴2 min。
- 加入900 μL无抗LB液体培养基,37 ℃、180 rpm振荡培养45 min(30 ℃条件下则培养1–1.5 h)。
- 6000 rpm离心5 min,弃上清,仅保留100 μL上清重悬菌体沉淀,涂布于对应质粒抗性的LB平板上。
- 平板倒置培养,37 ℃培养14 h,或30 ℃培养20 h。
- 挑取单菌落至LB液体培养基中,加入对应抗生素,220 rpm振荡培养14 h;根据实验需求及质粒提取试剂盒说明书提取质粒。
参考文献
- Carretero-Ortega J, Chhangawala Z, Hunt S, Narvaez C, Menéndez-González J, Gay CM, Zygmunt T, Li X, Torres-Vázquez J. GIPC proteins negatively modulate Plexind1 signaling during vascular development. Elife. 2019 May 3;8:e30454. doi: 10.7554/eLife.30454. PMID: 31050647; PMCID: PMC6499541.
LentiCRISPR v2-Blast 质粒 (编号: V016982) 注释
LOCUS LentiCRISPR-v2-B 14612 bp DNA circular SYN 30-DEC-2025
DEFINITION Exported.
ACCESSION V016982
VERSION .
KEYWORDS .
SOURCE synthetic DNA construct
ORGANISM synthetic DNA construct
REFERENCE 1 (bases 1 to 14612)
TITLE Direct Submission
REFERENCE 2 (bases 1 to 14612)
AUTHORS .
TITLE Direct Submission
COMMENT SGRef: number: 1; type: "Journal Article"
FEATURES Location/Qualifiers
source 1..14612
/mol_type="other DNA"
/organism="synthetic DNA construct"
enhancer 238..617
/label=CMV enhancer
/note="human cytomegalovirus immediate early enhancer"
promoter 618..820
/label=CMV promoter
/note="human cytomegalovirus (CMV) immediate early
promoter"
LTR 835..1015
/label=5' LTR (truncated)
/note="truncated 5' long terminal repeat (LTR) from HIV-1"
misc_feature 1062..1187
/label=HIV-1 Psi
/note="packaging signal of human immunodeficiency virus
type 1"
misc_feature 1680..1913
/label=RRE
/note="The Rev response element (RRE) of HIV-1 allows for
Rev-dependent mRNA export from the nucleus to the
cytoplasm."
CDS 2098..2142
/label=gp41 peptide
/note="antigenic peptide corresponding to amino acids 655
to 669 of the HIV envelope protein gp41 (Lutje Hulsik et
al., 2013)"
CDS 2291..2332
/label=Protein Tat
/note="Protein Tat from Human immunodeficiency virus type 1
group M subtype B (isolate WMJ22). Accession#: P12509"
misc_feature 2440..2557
/label=cPPT/CTS
/note="central polypurine tract and central termination
sequence of HIV-1"
promoter 2608..2848
/label=U6 promoter
/note="RNA polymerase III promoter for human U6 snRNA"
misc_RNA 4738..4813
/label=gRNA scaffold
/note="guide RNA scaffold for the Streptococcus pyogenes
CRISPR/Cas9 system"
promoter 4875..5086
/label=EF-1-alpha core promoter
/note="core promoter for human elongation factor
EF-1-alpha"
CDS 5111..9214
/label=Cas9
/note="Cas9 (Csn1) endonuclease from the Streptococcus
pyogenes Type II CRISPR/Cas system"
CDS 9263..9286
/label=FLAG
/note="FLAG(R) epitope tag, followed by an enterokinase
cleavage site"
CDS 9296..9352
/label=P2A
/note="2A peptide from porcine teschovirus-1 polyprotein"
CDS 9353..9748
/label=BSD
/note="blasticidin S deaminase"
CDS complement(10247..10258)
/label=Factor Xa site
/note="Factor Xa recognition and cleavage site"
LTR 10436..10669
/label=3' LTR (Delta-U3)
/note="self-inactivating 3' long terminal repeat (LTR) from
HIV-1"
polyA_signal 10701..10925
/label=bGH poly(A) signal
/note="bovine growth hormone polyadenylation signal"
rep_origin 10971..11399
/label=f1 ori
/note="f1 bacteriophage origin of replication; arrow
indicates direction of (+) strand synthesis"
promoter 11452..11662
/label=SV40 promoter
/note="SV40 early promoter"
promoter 11718..11765
/label=EM7 promoter
/note="synthetic bacterial promoter"
CDS 11784..12155
/label=BleoR
/note="antibiotic-binding protein"
polyA_signal 12288..12421
/label=SV40 poly(A) signal
/note="SV40 polyadenylation signal"
promoter complement(12506..12536)
/label=lac promoter
/note="promoter for the E. coli lac operon"
protein_bind complement(12551..12572)
/label=CAP binding site
/note="CAP binding activates transcription in the presence
of cAMP."
rep_origin complement(12860..13448)
/direction=LEFT
/label=ori
/note="high-copy-number ColE1/pMB1/pBR322/pUC origin of
replication"
CDS complement(13622..14479)
/label=AmpR
/note="beta-lactamase"
promoter complement(14480..14584)
/label=AmpR promoter